Fmcna - Gonzales is a medicare approved dialysis facility center in Gonzales, Louisiana and it has 17 dialysis stations. It is located in Ascension county at 2326 South Darla Ave, Gonzales, LA, 70737. You can reach out to the office of Fmcna - Gonzales at (225) 647-4814. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmcna - Gonzales has the following ownership type - Profit. It was first certified by medicare in September, 2016. The medicare id for this facility is 192730 and it accepts patients under medicare ESRD program.
| Name | Fmcna - Gonzales |
|---|---|
| Location | 2326 South Darla Ave, Gonzales, Louisiana |
| No. of Dialysis Stations | 17 |
| Medicare ID | 192730 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2326 South Darla Ave, Gonzales, Louisiana, 70737 | |
| (225) 647-4814 | |
| Not Available |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago
| NPI Number | 1861889289 |
| Organization Name | Fresenius Medical Care Gonzales |
| Doing Business As | Fresenius Medical Care Capital City, Llc |
| Address | 2326 South Darla Avenue Gonzales, Louisiana, 70737 |
| Phone Number | (225) 928-5210 |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 9 |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 277 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmcna - Gonzales with elevated calcium levels.
| Patients with hypercalcemia | 37 |
| Hypercalcemia patient months | 281 |
| Patients with Serumphosphor | 39 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 30 |
| Patients with Serumphosphor greater than 7 mg/dL | 19 |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 44 |
| Patient months included in arterial venous fistula and catheter summaries | 202 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 63 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods, including several processed baby foods, collected from the agency's Total Diet Study (TDS), which monitors levels of nutrients and contaminants in foods consumed in the U.S.
FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new technique to more precisely analyze bacterial populations, to reveal epigenetic mechanisms that can drive virulence. The new methods hold the promise of a potent new tool to offset the growing challenge of antibiotic resistance by bacterial pathogens.
New research by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington shows that innovative and improved methods for analyzing verbal autopsies - a method of determining individuals' causes of death in countries without a complete vital registration system - are fast, effective, and inexpensive, and could be invaluable for countries struggling to understand disease trends.
› Verified 3 days ago